{
    "clinical_study": {
        "@rank": "90839", 
        "arm_group": [
            {
                "arm_group_label": "Video Group", 
                "arm_group_type": "Experimental", 
                "description": "Subjects view educational video on the use of cream medication for the treatment of actinic keratoses."
            }, 
            {
                "arm_group_label": "Verbal Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects are given verbal instructions on the use of cream medication for the treatment of actinic keratoses."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary aim of this study is to evaluate the effects of prospective patient education on\n      patient satisfaction with administration of topical 5% 5-fluorouracil cream for the\n      treatment of actinic keratosis involving the face, scalp, upper chest, dorsal hands and\n      forearms. Specifically, this study aims to determine if prospective patient viewing of an\n      educational video delineating treatment effects and expectations improves patient\n      satisfaction and treatment completion rates."
        }, 
        "brief_title": "Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Actinic Keratoses", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with a clinical diagnosis of actinic keratoses with at least 6\n             clinically-diagnosed actinic keratoses on the face, bald scalp, arms, upper chest, OR\n             dorsal hands classified as grade I, mild (slightly palpable actinic keratoses, more\n             easily felt than seen), and II, moderate (moderately thick hyperkeratotic actinic\n             keratoses, easily felt).\n\n        Exclusion Criteria:\n\n          -  Patients using interferon or interferon inducers, immunomodulators, cytotoxic or\n             immunosuppressor drugs, corticosteroids, retinoids, or investigational drugs within 4\n             weeks prior to enrollment.\n\n          -  Patients who have been treated with any topical drug for actinic keratoses lesions\n             less than 8 weeks prior to enrollment.\n\n          -  Patients with invasive tumors within the treated area (e.g. invasive squamous cell\n             carcinoma)\n\n          -  Patients who have exhibited any dermatological disease within the treated or adjacent\n             (3 cm distance) area at the time of screening.\n\n          -  Patients who have known allergies to fluorouracil (5-FU)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062853", 
            "org_study_id": "384968", 
            "secondary_id": "384968"
        }, 
        "intervention": [
            {
                "arm_group_label": "Video Group", 
                "description": "Subjects will view a brief video today (about 5 minutes long) that provides information on the cream medication that will be used for treatment of your actinic keratoses.", 
                "intervention_name": "Video Group", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Verbal Group", 
                "description": "The physician will provide information about the cream medication for the treatment of actinic keratoses through a regular conversation.", 
                "intervention_name": "Verbal Group", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "link": {
            "description": "University of California-Davis Department of Dermatology Clinical Research", 
            "url": "http://www.ucdmc.ucdavis.edu/dermatology/clinical_research"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Sacramento", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95816"
                }, 
                "name": "University of California-Davis, Department of Dermatology"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "CQI Pilot Study Evaluating the Utility of an Educational Video in the Setting of Topical 5-fluorouracil Therapy to Treat Actinic Keratoses and Its Influence on Patient Satisfaction", 
        "overall_official": {
            "affiliation": "University of California, Davis", 
            "last_name": "Nasim Fazel, M.D., D.D.S.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The level of patient satisfaction will be assessed via questionnaire and visual analog scale.", 
            "measure": "Level of Patient Satisfaction in Relation to Treatment Effects and Expectations of 5-fluorouracil Cream", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062853"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of California, Davis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, Davis", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}